Web Results
Alemtuzumab Highlights
ALEMTUZUMAB (AL em TOOZ oo mab) is a monoclonal antibody. Campath is used to treat B cell chronic lymphocytic leukemia. Lemtrada is used to treat multiple sclerosis. More »
Source: healthline.com

Alemtuzumab

en.wikipedia.org/wiki/Alemtuzumab

Alemtuzumab is a drug used in the treatment of chronic lymphocytic leukemia ( CLL), cutaneous T-cell lymphoma (CTCL) and T-cell lymphoma under the trade ...

Campath (Alemtuzumab) Drug Information: Description, User ...

www.rxlist.com/campath-drug.htm

Learn about the prescription medication Campath (Alemtuzumab), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling.

FDA Approval for Alemtuzumab (Lemtrada) in MS - Medscape

www.medscape.com/viewarticle/834994

Nov 15, 2014 ... Alemtuzumab (Lemtrada) has received long-awaited FDA approval in relapsing multiple sclerosis.

drugsaz.about.com/od/drugs/alemtuzumab.htm
Los hombre y las mujeres deben usar métodos anticonceptivos efectivos durante el tratamiento y por lo menos 6 meses después de dejar de usar este medicamento. Call your doctor or health care professional if you are unable to keep an appointment. Comuníquese con su méd... More »

FDA Approves Lemtrada™ (alemtuzumab) for Relapsing MS ...

www.nationalmssociety.org/About-the-Society/News/FDA-Approves-Lemtrada™-(alemtuzumab)-for-Relapsing

Nov 14, 2014 ... UPDATED December 18, 2014. The U.S. Food and Drug Administration has approved Lemtrada™ (alemtuzumab, Genzyme, a Sanofi ...

Relapsing MS Infusion Treatment | LEMTRADA® (alemtuzumab)

www.lemtrada.com/

LEMTRADA®, because of its risks, is generally for relapsing MS patients who have tried 2 or more MS medicines that didn't work well enough.

Alemtuzumab (marketed as Campath) Information - Food and Drug ...

www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm082681.htm

Jul 8, 2015 ... This is a summary of the most important information about Campath. For more information, talk to your healthcare professional.

Alemtuzumab (MabCampath) | Cancer Research UK

www.cancerresearchuk.org/about-cancer/cancers-in-general/treatment/cancer-drugs/alemtuzumab

Dec 17, 2015 ... The biological therapy drug alemtuzumab is a treatment for chronic lymphocytic leukaemia. The possible side effects inlcude an increased risk ...

alemtuzumab intravenous : Uses, Side Effects, Interactions, Pictures ...

www.webmd.com/drugs/2/drug-21057/alemtuzumab-intravenous/details

Find patient medical information for alemtuzumab intravenous on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ...

Popular Q&A
Q: What is alemtuzumab?
A: Alemtuzumab is an antibody made from animal DNA. Alemtuzumab is used to treat chronic B-cell lymphocytic leukemia. Alemtuzumab may also be used for purposes not... Read More »
Source: www.drugs.com
Q: What is alemtuzumab?
A: Alemtuzumab is an antibody made from animal DNA. Alemtuzumab is used to treat chronic lymphocytic leukemia. Alemtuzumab is usually given after other medications... Read More »
Source: www.cigna.com
Q: What is dosage of Alemtuzumab ?
A: General Premedication and Patient Monitoring To minimize risk of IV infusion-related reactions, administer diphenhydramine hydrochloride 50 mg and acetaminophen... Read More »
Source: www.drugs.com
Q: What is alemtuzumab (Campath)?
A: Alemtuzumab is an antibody made from animal DNA. Alemtuzumab is used to treat chronic lymphocytic leukemia. Alemtuzumab is usually given after other medications... Read More »
Source: www.rxlist.com
Helpful Resources

Campath.com Consumer Home

www.campath.com

Campath, alemtuzumab is a major step forward in the treatment of B-cell chronic lymphocytic leukemia (B-CLL).